Table 1. Inhibition of insulin release from rat pancreatic islets by inhibitors of α-ketoglutarate hydroxylases.
Secretagogue | Inhibitor | Insulin Release(μU Insulin/5 islets/ 60 min.) |
---|---|---|
None | None | 20 ± 2 |
Glucose | None | 841 ± 63 |
Glucose | 1 mM Ethyl-3,4-dihydroxybenzoate | 48 ± 5a |
Glucose | 10 mM 2-Methyl-α-ketoglutarate | 54 ± 7a |
Glucose | 5 mM 2-Methyl-α-ketoglutarate | 291 ± 21a |
Glucose | 10 mM 3-Methyl-α-ketoglutarate | 315 ± 29a |
Leucine + glutamine | None | 1094 ± 105 |
Leucine + glutamine | 1 mM Ethyl-3,4-dihydroxybenzoate | 72 ± 24a |
p < 0.001 vs same secretagogue condition without inhibitor